MAURICIO J. DULFANO, M.D.
This content is PDF only. Please click on the PDF icon to access.
The previously undisputed benefits of isoproterenol, epinephrine, and aminophylline in treatment of bronchial asthma have recently come under critical review. For decades pulmonary physiologists characterized the asthmatic disturbance primarily in terms of increased work of breathing resulting from augmented airway resistance and uneven distribution of ventilation throughout the lung, while little attention was directed to the characteristics of pulmonary blood flow (Q) distribution, and the resultant effects on alveolar ventilation-perfusion ratios (VA/QT), "physiological" shunt (QS/QT), and the alveolar-arterial oxygen tension gradient (A-ao2D). The concept that hypoxemia and hypercapnia are infrequent in asthma (1) went unchallenged for years until convincing evidence
DULFANO MJ. Bronchodilators, Pulmonary Function, and Asthma. Ann Intern Med. ;68:955–956. doi: 10.7326/0003-4819-68-4-955
Download citation file:
Published: Ann Intern Med. 1968;68(4):955-956.
Asthma, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use